Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bongin Yoo

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Journal (Sudbury, Mass.)|September 22, 2015
Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Metastatic Breast Cancer Previously Treated With Chemotherapy and 2 or More HER2-Targeted Agents: Results From the T-PAS Expanded Access StudyDenise A Yardley, Ian E Krop, Patricia M LoRusso, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 22, 2021
Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRANicola A Hanania, Spyridon Fortis, Tmirah Haselkorn, et al.
Breast Cancer Research and Treatment|April 8, 2014
Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancerDenise A Yardley, Peter A Kaufman, Adam Brufsky, et al.
The Oncologist|May 9, 2013
First-line treatment patterns and clinical outcomes in patients with HER2-positive and hormone receptor-positive metastatic breast cancer from registHERDebu Tripathy, Peter A Kaufman, Adam M Brufsky, et al.
Neurosurgery|September 21, 2007
Improving prediction of outcome in "good grade" subarachnoid hemorrhageEnrique C Leira, Patricia H Davis, Coleman O Martin, et al.
Breast Cancer Research and Treatment|September 25, 2013
Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancerHope S Rugo, Adam M Brufsky, Marianne Ulcickas Yood, et al.
Annals of Neurology|November 23, 2006
Effects of intraoperative hypothermia on neuropsychological outcomes after intracranial aneurysm surgerySteven W Anderson, Michael M Todd, Bradley J Hindman, et al.
BMC Cancer|June 3, 2014
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerDebu Tripathy, Hope S Rugo, Peter A Kaufman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2018
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket StudyJohn D Hainsworth, Funda Meric-Bernstam, Charles Swanton, et al.
Cancer|June 17, 2014
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancerPeter A Kaufman, Kenneth J Bloom, Howard Burris, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Journal (Sudbury, Mass.)|September 22, 2015
Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Metastatic Breast Cancer Previously Treated With Chemotherapy and 2 or More HER2-Targeted Agents: Results From the T-PAS Expanded Access StudyDenise A Yardley, Ian E Krop, Patricia M LoRusso, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 22, 2021
Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRANicola A Hanania, Spyridon Fortis, Tmirah Haselkorn, et al.
Breast Cancer Research and Treatment|April 8, 2014
Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancerDenise A Yardley, Peter A Kaufman, Adam Brufsky, et al.
The Oncologist|May 9, 2013
First-line treatment patterns and clinical outcomes in patients with HER2-positive and hormone receptor-positive metastatic breast cancer from registHERDebu Tripathy, Peter A Kaufman, Adam M Brufsky, et al.
Neurosurgery|September 21, 2007
Improving prediction of outcome in "good grade" subarachnoid hemorrhageEnrique C Leira, Patricia H Davis, Coleman O Martin, et al.
Breast Cancer Research and Treatment|September 25, 2013
Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancerHope S Rugo, Adam M Brufsky, Marianne Ulcickas Yood, et al.
Annals of Neurology|November 23, 2006
Effects of intraoperative hypothermia on neuropsychological outcomes after intracranial aneurysm surgerySteven W Anderson, Michael M Todd, Bradley J Hindman, et al.
BMC Cancer|June 3, 2014
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerDebu Tripathy, Hope S Rugo, Peter A Kaufman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2018
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket StudyJohn D Hainsworth, Funda Meric-Bernstam, Charles Swanton, et al.
Cancer|June 17, 2014
Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancerPeter A Kaufman, Kenneth J Bloom, Howard Burris, et al.
Pageof 3